Journal of Inherited Metabolic Disease · 1999 · 18 citations · 7 references
Life SciencesGeneticsMolecular GeneticsGenomicsHuman GeneticsMedical GeneticsGenetic DisordersLoss Of HeterozygosityMendelian DisordersMutation AnalysisMutation ScreeningVariant InterpretationDeletion MutationsGenomic Deletion DetectionHomozygous DeletionMissense MutationsMutant Detection
The clinical use of molecular analyses in recessive disorders relies on the exact characterization of both mutant alleles in the affected patient. This can be problematic when only part of the gene is examined or when relevant DNA alterations are not recognized by standard methods. We present a child in whom phenylketonuria was apparently caused by homozygosity for the mutation E390G in exon 11 of the phenylalanine hydroxylase (PAH) gene. However, the clinical severity of the disease was not quite as mild as expected, the mutation was not identified in the father despite confirmed paternity, and the paternal allele showed a highly unusual pattern of polymorphic markers in the PAH gene. Presence of a large deletion involving exons 9, 10 and 11 of the phenylalanine hydroxylase gene was confirmed by long-range PCR. Diagnostic DNA analyses should include a comprehensive examination of the whole relevant gene in the patient and confirmation of carrier status in both parents.
7
Per Guldberg, Françoise Rey, Johannes Zschocke et al. · The American Journal of Human Genetics · 1998 · 357 citations · Full text
A single origin of phenylketonuria in Yemenite Jews
Smadar Avigad, B. E. Cohen, Sofía Bauer et al. · Nature · 1990 · 70 citations
The PAH mutation analysis consortium database: update 1996
Przemysław Nowacki, Susan Byck, Lynne Prevost et al. · Nucleic Acids Research · 1997 · 37 citations